Philadelphia, Pa., Feb. 27, 2018 -- The Adult Congenital Heart Association (ACHA) applauds the House of Representatives for passage of the Congenital Heart Futures Reauthorization Act (CHFRA), H.R. 1222.
|
|||
Congenital heart defects are the most prevalent category of birth defects, affecting nearly 1 in 100 babies; more than five percent will not live to see their first birthday, and those who receive successful intervention are not cured. Children and adults with congenital heart disease (CHD) require ongoing, costly, specialized cardiac care, and face a lifelong risk of permanent disability and premature death.
This legislation will ensure that critical CHD activities at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) will continue. First authorized in 2010, these efforts have improved our understanding of CHD across the lifespan, the age-specific prevalence of CHD, and factors impacting when people with CHD do not receive appropriate specialty care. House passage of CHFRA is the first step to allowing the CDC and NIH to build upon their existing programs to address an important public health issue and improve the quality of life and care for individuals with CHD.
“We applaud the House of Representatives on passage of the Congenital Heart Futures Reauthorization Act, which will improve the lives of all people with CHDs in our country. The entire CHD community also extends a special thanks to Representatives Gus Bilirakis and Adam Schiff for their leadership in introducing CHFRA and their tireless work for it to be considered in the House,” said Mark Roeder, President and CEO of ACHA. “Now, we will turn our attention to the Senate, in hopes that it, too, will act and CHFRA will become law this year.”
More than 180 Adult Congenital Heart Association advocates from 32 different states will be on Capitol Hill in Washington, D.C. this week, thanking House of Representatives members who have continued to support individuals with congenital heart disease (CHD) and ensuring U.S. Senators are informed and educated on this critical bi-partisan issue.
###
About the Adult Congenital Heart Association
The Adult Congenital Heart Association (ACHA) is a national not-for-profit organization dedicated to improving the quality of life and extending the lives of adults with congenital heart disease (CHD). ACHA serves and supports the more than one million adults with CHD, their families and the medical community—working with them to address the unmet needs of the long-term survivors of congenital heart defects through education, outreach, advocacy, and promotion of ACHD research. For more information about ACHA, contact (888) 921-ACHA or visit www.achaheart.org.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b41a6b8e-25fb-48eb-a477-0055113cf894
Chris Murray Adult Congenital Heart Association (610) 254-7422 [email protected]


DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
OpenAI Restricts Astra AI Over Cyberattack Risks
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 



